Tumor-targeted radionuclide therapy: Trial design driven by patient dosimetry

被引：0

作者：

DeNardo, SJ ^{[1
]}

机构：

[1] Univ Calif Davis, Med Ctr, Sacramento, CA 95816 USA

来源：

JOURNAL OF NUCLEAR MEDICINE | 2000年 / 41卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：104 / 106

页数：3

共 26 条

[1] Radiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin [J].

Breitz, HB ;

Fisher, DR ;

Goris, ML ;

Knox, S ;

Ratliff, B ;

Murtha, AD ;

Weiden, PL .

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1999, 14 (05) :381-395

[2] REQUIREMENTS FOR A TREATMENT PLANNING SYSTEM FOR RADIOIMMUNOTHERAPY [J].

DENARDO, GL ;

RAVENTOS, A ;

HINES, HH ;

SCHEIBE, PO ;

MACEY, DJ ;

HAYS, MT ;

DENARDO, SJ .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (02) :335-348

[3] QUANTITATIVE SPECT OF UPTAKE OF MONOCLONAL-ANTIBODIES [J].

DENARDO, GL ;

MACEY, DJ ;

DENARDO, SJ ;

ZHANG, CG ;

CUSTER, TR .

SEMINARS IN NUCLEAR MEDICINE, 1989, 19 (01) :22-32

[4]

DENARDO GL, 1988, RADIOLABELED MONOCLO, P293

[5] A new era for radiolabeled antibodies in cancer? [J].

DeNardo, SJ ;

Kroger, LA ;

DeNardo, GL .

CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (05) :563-569

[6]

Howell RW, 1999, J NUCL MED, V40, p3S

[7]

Juweid ME, 1997, CANCER, V80, P2749

[8]

Juweid ME, 2000, J NUCL MED, V41, P93

[9] Innovations in three-dimensional treatment planning and quality assurance [J].

Michalski, JM ;

Purdy, JA .

TUMORI, 1998, 84 (02) :127-139

[10]

PRESS OW, 1990, FRONT RADIAT THER ON, V24, P204

← 1 2 3 →